about
A murine model of ulcerative colitis: induced with sinusitis-derived superantigen and food allergenStructural basis for abrogated binding between staphylococcal enterotoxin A superantigen vaccine and MHC-IIαPathogenesis of group A streptococcal infectionsClinically mild encephalitis/encephalopathy with a reversible splenial lesion caused by methicillin-sensitive Staphylococcus aureus bacteremia with toxic shock syndrome: a case report.Detection of staphylococcal superantigenic toxins by a CD69-specific cytofluorimetric assay measuring T-cell activation.Rapamycin protects mice from staphylococcal enterotoxin B-induced toxic shock and blocks cytokine release in vitro and in vivo.Construction of a single-chain variable-fragment antibody against the superantigen Staphylococcal enterotoxin BActivation of bovine lymphocyte subpopulations by staphylococcal enterotoxin C.The role of the cell-mediated immune response to Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in periodontitis.Opsonic antibodies to the surface M protein of group A streptococci in pooled normal immunoglobulins (IVIG): potential impact on the clinical efficacy of IVIG therapy for severe invasive group A streptococcal infections.Localization of a T-cell epitope of superantigen toxic shock syndrome toxin 1 to residues 125 to 158.Immune response to staphylococcal superantigens.Potent neutralization of staphylococcal enterotoxin B by synergistic action of chimeric antibodiesStimulant-dependent modulation of cytokines and chemokines by airway epithelial cells: cross talk between pulmonary epithelial and peripheral blood mononuclear cells.Multiplex PCR for detection of genes for Staphylococcus aureus enterotoxins, exfoliative toxins, toxic shock syndrome toxin 1, and methicillin resistance.Coordinate suppression of superantigen-induced cytokine production and T-cell proliferation by a small nonpeptidic inhibitor of class II major histocompatibility complex and CD4 interactionA response regulator that represses transcription of several virulence operons in the group A streptococcus.Characterization of a putative pathogenicity island from bovine Staphylococcus aureus encoding multiple superantigens.Pentoxifylline inhibits superantigen-induced toxic shock and cytokine release.Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity.Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection casesChimeric anti-staphylococcal enterotoxin B antibodies and lovastatin act synergistically to provide in vivo protection against lethal doses of SEB.Severe group A streptococcal infection and streptococcal toxic shock syndrome.Acute septic arthritis.Group A Streptococcus: allelic variation, population genetics, and host-pathogen interactions.Dexamethasone attenuates staphylococcal enterotoxin B-induced hypothermic response and protects mice from superantigen-induced toxic shock.Bacterial infections and atopic dermatitis.Lysogenic transfer of group A Streptococcus superantigen gene among StreptococciComparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).Fatal case of toxic shock-like syndrome due to group C streptococcus associated with superantigen exotoxinUncoupling of T cell receptor zeta chain function during the induction of anergy by the superantigen, staphylococcal enterotoxin APreferential induction of septic arthritis and mortality by superantigen-producing staphylococci.Analysis of the superantigenic activity of mutant and allelic forms of streptococcal pyrogenic exotoxin AIntranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice.Mitogenic activities of amino acid substitution mutants of staphylococcal enterotoxin B in human and mouse lymphocyte cultures.Immunogenicity and efficacy against lethal aerosol staphylococcal enterotoxin B challenge in monkeys by intramuscular and respiratory delivery of proteosome-toxoid vaccines.Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G.Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates.Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience.
P2860
Q24805134-022E7B39-AA19-4132-A08E-5FD81A776D34Q27637839-621AC652-9F5F-4D97-8240-8EE860626C59Q29615547-51DD6347-AE65-4A32-B849-593C44ACBA42Q33431588-3F77EF16-6A30-4506-8EB0-97584B7130ADQ33661853-B05F9BE1-FC0C-43C6-9DB7-BF849E2E18D1Q33676236-7E406331-EC94-4EEB-B89F-E0E7BBED86C7Q33720576-3508E374-95CA-4297-9E89-4AC2FBF528A2Q33750234-4257F4E0-095A-44D3-9236-64248A4E910BQ33752057-D7513C8C-9012-4A3F-B53F-3DBBF9FA32D7Q33753988-F1D63A43-7210-4E1E-BD0A-65CCD00DE01AQ33766618-0E59E00E-69A7-49AF-BE45-5FD87EEDD550Q33784073-1318F197-B501-4F47-B6B2-8D386A0E2A27Q33877190-FD30B6B3-2800-445C-BE7D-B8B240F84D51Q33941909-FBE8AF70-4365-4FE6-80DA-ECD293042C33Q33965952-6BA3A2BA-E2B5-498A-B7A5-E706DEA02065Q33979258-4D28C50B-AD07-4F83-B9FB-B1B9BE070834Q33992290-1F52A01A-CAB1-4166-8D8B-6A323ABC3917Q33995165-44FC62FC-DC4D-4D8B-BC54-1F7355E50B8AQ33997794-D61A130C-7C43-46D6-9974-65F6CD35CE30Q34000926-01C5C723-27B6-4C41-A113-148FE8EA18C3Q34005015-CC856F6F-6C63-4A03-A207-D194C5A50A85Q34079264-A45AF949-B91B-4E8D-B623-CBE727FA9631Q34093273-41A017BF-F60B-4002-B85C-8866ED865DE7Q34102880-70F81CC5-51E4-432E-9312-9AE8DD9F6C59Q34142091-D92E4377-D994-4597-AF5D-9DD4B5402433Q34301653-7D59BB61-B06B-4669-A4C4-48870BEDFDCBQ34434591-79787AFC-2142-472C-8F5C-C7E39ADAB3FCQ34539675-8F0AE37A-13E8-40E7-ABDE-5A08F0CB976DQ34544467-E877DB07-552D-4469-BB22-AE7C0423B927Q34546630-4104F348-4C79-4202-BE8C-98F843F9D96BQ34782834-0D5BABBE-8049-4FCC-895C-DF5C1229D9F3Q35155871-5045E14C-3531-4FC6-9774-1E4377AF706CQ35446934-FBE3A008-15D2-4602-9913-133AC918A069Q35474129-4FC6FDBB-DBE6-48A0-8CA5-55F210260393Q35490149-7692D3A7-A995-4AFF-A042-153A5052BD1CQ35510006-FBCB673D-3D5C-4542-97BE-81ED64B07D74Q35529377-F13C8BEE-B78B-4E30-9126-4B765C567FB8Q35532764-6631F6C4-6D3B-42A9-AE0E-603DCFA66710Q35560485-1C56B9EF-1388-4A67-9946-6CEBE28757A6Q35585094-B7E81F1B-ADE5-4776-92D1-BD84EA99548A
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Role of superantigens in human disease.
@en
type
label
Role of superantigens in human disease.
@en
prefLabel
Role of superantigens in human disease.
@en
P356
P1476
Role of superantigens in human disease.
@en
P2093
Schlievert PM
P304
P356
10.1093/INFDIS/167.5.997
P407
P577
1993-05-01T00:00:00Z